This is a news story, published by New Atlas, that relates primarily to BED news.
For more drug discoveries news, you can click here:
more drug discoveries newsFor more news from New Atlas, you can click here:
more news from New AtlasOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
amphetamine use. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest methamphetamine use news, methamphetamine use disorder news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
ADHD drugNew Atlas
•Health
Health
83% Informative
Lisdexamfetamine is a relatively new central nervous system stimulant prescribed for attention deficit hyperactivity disorder (ADHD) and binge eating disorder ( BED ) It’s one of a class of drugs called psychostimulants that works by improving the way parts of the brain communicate with one another.
There is currently no pharmacotherapy approved for treating methamphetamine dependence.
VR Score
81
Informative language
80
Neutral language
58
Article tone
informal
Language
English
Language complexity
63
Offensive language
likely offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
4
Affiliate links
no affiliate links
